AQUA Therapeutics Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Out of Business

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Out of Business

AQUA Therapeutics General Information

Description

Provider of medical research and consulting services intended to treat fibrotic diseases. The company's services produce drugs through conventional drug discovery technology, low molecule, and antibody drugs, enabling the healthcare industry to develop innovative therapeutic drugs using nucleic acid drugs in order to bring about a major change in the treatment of all fibrotic diseases.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Sannomiya Denden Building 3F
  • 64 Naniwamachi,Chuo-ku
  • Kobe
  • Japan
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Vertical(s)
Corporate Office
  • Sannomiya Denden Building 3F
  • 64 Naniwamachi,Chuo-ku
  • Kobe
  • Japan

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AQUA Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business 15-Oct-2021 Completed Out of Business
3. Secondary Transaction - Private 01-Aug-2021 Completed Generating Revenue
2. Early Stage VC 11-Sep-2015 $4.09M $9.1M Completed Generating Revenue
1. Early Stage VC (Series A) 01-Aug-2013 $5.02M $5.02M Completed Generating Revenue
To view AQUA Therapeutics’s complete valuation and funding history, request access »

AQUA Therapeutics Patents

AQUA Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2018030451-A1 Therapeutic agent for adhesion, method for treating adhesion, postoperative adhesion marker, and method for examining susceptibility to postoperative adhesion Inactive 09-Aug-2016
WO-2017026496-A1 Periostin gene expression-suppressing nucleic acid molecule, method for suppressing expression of periostin gene, and application therefor Inactive 10-Aug-2015
EP-3047852-A1 Drug for disease caused by expression of periostin except eye disease, and use thereof Inactive 27-Sep-2013
US-20160304866-A1 Drug for disease caused by expression of periostin except eye disease, and use thereof Inactive 27-Sep-2013
WO-2015046451-A1 Drug for disease caused by expression of periostin except eye disease, and use thereof Inactive 27-Sep-2013 C12N15/113
To view AQUA Therapeutics’s complete patent history, request access »

AQUA Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

AQUA Therapeutics FAQs

  • When was AQUA Therapeutics founded?

    AQUA Therapeutics was founded in 2012.

  • Where is AQUA Therapeutics headquartered?

    AQUA Therapeutics is headquartered in Kobe, Japan.

  • What is the size of AQUA Therapeutics?

    AQUA Therapeutics has 2 total employees.

  • What industry is AQUA Therapeutics in?

    AQUA Therapeutics’s primary industry is Drug Discovery.

  • Is AQUA Therapeutics a private or public company?

    AQUA Therapeutics is a Private company.

  • What is AQUA Therapeutics’s current revenue?

    The current revenue for AQUA Therapeutics is .

  • How much funding has AQUA Therapeutics raised over time?

    AQUA Therapeutics has raised $9.1M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process